Hui Wang

机构：Shenzhen Third People’s Hospital · ORCID：0000-0001-7899-7144

发表论文 42 篇 · 总被引 456 次 · h-index 10

代表论文

• Emergence of a multidrug-resistant and virulent Streptococcus pneumoniae lineage mediates serotype replacement after PCV13: an international whole-genome sequencing study (2022 · The Lancet Microbe · 被引 106)
• Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma (2023 · Frontiers in Immunology · 被引 76)
• Mechanism exploration of Zoledronic acid combined with PD-1 in the treatment of hepatocellular carcinoma (2024 · Cancer Immunology Immunotherapy · 被引 6)
• Bortezomib in previously treated phosphatase and tension homology‐deficient patients with advanced intrahepatic cholangiocarcinoma: An open‐label, prospective and single‐centre phase II trial (2024 · Clinical and Translational Medicine · 被引 5)
• Operative versus Nonoperative Treatment in Patients with Advanced Non-Small-Cell Lung Cancer: Recommended for Surgery (2023 · Canadian Respiratory Journal · 被引 4)
• Analysis of pathological changes and related factors in liver tissue of HBeAg-negative patients with low HBsAg levels (2020 · Clinical and Experimental Medicine · 被引 1)